COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 01:00, il y a 1 année 4 mois Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options Onco-Innovations Limited announces exclusive-licensed PNKP inhibitors Technology targeting cancer cells to enhance treatment effectiveness across various cancer types including colorectal, breast, and lung cancer Clinical Trials Cancer Treatment Oncology Market Onco-Innovations Limited PNKP Inhibitors Technology
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 01:00, il y a 1 année 4 mois BeWhere Holdings Inc. Announces Expedited Acquisition and Appointment of Board Member BeWhere Holdings Inc. acquires 100% of a US Corporation for USD600,000 cash and equity. Peter Wilcox appointed to the Board of Directors. Company focuses on mobile IoT solutions for asset tracking and connected sensors Acquisition Board Of Directors IoT Solutions BeWhere Holdings Inc. Mobile Applications
COMMUNIQUÉ DE PRESSE publié le 08/01/2025 à 22:30, il y a 1 année 4 mois Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter Applied DNA Sciences reschedules Investor Update call to February 13, 2025, coinciding with Q1 fiscal 2025 results release due to National Day of Mourning. Company develops PCR-based technologies Financial Results Applied DNA Sciences Investor Update PCR-based Technologies Rescheduled Call
COMMUNIQUÉ DE PRESSE publié le 08/01/2025 à 22:15, il y a 1 année 4 mois Rockhaven Resources Ltd. Closes Private Placement Rockhaven Resources Ltd. closes non-brokered private placement offering, raising $1,000,000 for further exploration at Klaza Gold-Silver Project. Related parties participate in the placement Exploration Private Placement Offering Related Parties Rockhaven Resources Ltd. Klaza Gold-Silver Project
COMMUNIQUÉ DE PRESSE publié le 08/01/2025 à 21:40, il y a 1 année 4 mois Blockchain Loyalty Corp., Also Known as Belle Bonica Luxe Corp., May Pursue Legal Action Against its Former Transfer Agent, Legacy Stock Transfer Inc. for Obstruction and Breach of Duty Blockchain Loyalty Corp. considers legal action against former transfer agent Legacy Stock Transfer for obstructive conduct, breach of fiduciary duty, and misconduct. The company strives for accountability and transparency Transparency Legal Action Blockchain Loyalty Corp. Legacy Stock Transfer Shareholder Accountability
COMMUNIQUÉ RÉGLEMENTÉ publié le 08/01/2025 à 19:05, il y a 1 année 4 mois Total number of voting rights and shares making up the share capital at December 31, 2024 Compagnie de Saint-Gobain – Société anonyme discloses total number of voting rights and shares as of December 31, 2024, in accordance with French regulations Share Capital Voting Rights French Regulations Compagnie De Saint-Gobain Total Number
COMMUNIQUÉ RÉGLEMENTÉ publié le 08/01/2025 à 19:05, il y a 1 année 4 mois Capital et droits de vote au 31 décembre 2024 Communiqué mensuel sur le nombre total d'actions et de droits de vote de la Compagnie de Saint-Gobain Autorité Des Marchés Financiers Droits De Vote Capital Social Compagnie De Saint-Gobain Code De Commerce
COMMUNIQUÉ DE PRESSE publié le 08/01/2025 à 18:30, il y a 1 année 4 mois PREDILIFE DOUBLE SON VOLUME DE VENTE EN 2024 ET ANTICIPE UNE FORTE CROISSANCE POUR 2025 Predilife double son volume de vente en 2024 et anticipe une forte croissance pour 2025. Découvrez les détails de cette progression et les perspectives prometteuses Croissance Vente Entreprise PREDILIFE Bilans Prédictifs
COMMUNIQUÉ DE PRESSE publié le 08/01/2025 à 18:24, il y a 1 année 4 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 20,000 of its own 'A' ordinary shares at an average price of 594.5000 GBp each through Numis Securities Limited as part of the share buyback program Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Purchase 'A' Ordinary Shares
COMMUNIQUÉ DE PRESSE publié le 08/01/2025 à 18:22, il y a 1 année 4 mois Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc purchases 198,338 Ordinary Shares for cancellation at an average price of 123.9587p each, reducing issued shares to 326,743,046 London Stock Exchange Ordinary Shares Share Buyback Funding Circle Plc Investec Bank Plc
Publié le 22/05/2026 à 19:35, il y a 17 heures 7 minutes PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Publié le 22/05/2026 à 18:05, il y a 18 heures 36 minutes Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Publié le 22/05/2026 à 18:05, il y a 18 heures 36 minutes Disclosure of transactions in own shares from May 18 to May 22, 2026
Publié le 22/05/2026 à 12:52, il y a 23 heures 49 minutes Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Publié le 22/05/2026 à 12:52, il y a 23 heures 49 minutes Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Publié le 23/05/2026 à 03:15, il y a 9 heures 27 minutes UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Publié le 23/05/2026 à 03:00, il y a 9 heures 42 minutes Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Publié le 23/05/2026 à 02:25, il y a 10 heures 17 minutes Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Publié le 23/05/2026 à 02:25, il y a 10 heures 17 minutes Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Publié le 23/05/2026 à 01:00, il y a 11 heures 42 minutes LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Publié le 22/05/2026 à 22:05, il y a 14 heures 37 minutes Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Publié le 22/05/2026 à 22:05, il y a 14 heures 37 minutes Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Publié le 22/05/2026 à 19:51, il y a 16 heures 50 minutes Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Publié le 22/05/2026 à 18:33, il y a 18 heures 9 minutes Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Publié le 22/05/2026 à 18:30, il y a 18 heures 11 minutes Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors